Published in Clin Drug Investig on January 01, 2007
Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci (2013) 2.15
Diabetes in Asians. Endocrinol Metab (Seoul) (2015) 1.39
Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations. Diabetes Metab Syndr Obes (2012) 0.91
Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients. Ther Clin Risk Manag (2014) 0.86
On the potential of acarbose to reduce cardiovascular disease. Cardiovasc Diabetol (2014) 0.84
A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients. Health Qual Life Outcomes (2011) 0.80
Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes. Open Heart (2015) 0.78
Postmarketing surveillance of acarbose treatment in Taiwanese patients with type 2 diabetes mellitus. Clin Drug Investig (2006) 0.96
Efficacy and safety of nifedipine GITS in Asians with hypertension: results of a post-marketing surveillance study in China. Clin Drug Investig (2007) 0.81
Efficacy and safety of nifedipine GITS in Chinese patients with hypertension--a post-marketing surveillance study. Blood Press Suppl (2007) 0.81
Nifedipine OROS in Chinese patients with hypertension--results of a post-marketing surveillance study in Taiwan. Blood Press Suppl (2005) 0.75